The Report Antibody Target, Technology & Pipeline Database: 1-Year Subscription provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz
Subscription to La Merie Publishing’s proprietary Antibody Database provides online access to information about more than 2,400 project entries for therapeutic antibodies on the market and in research & development. Pre-established and free search functions allow to identify antibodies according to their
Technology (e.g. antibody-drug conjugate, bispecific, isotype, phage display)
Target (e.g. Her2, CD20, TNF, PD-1/PD-L1)
Pipelines (selected by target, therapeutic area, company, technology)
Sales (for marketed antibodies)
R&D Phase (clinical phases, market, preclinical)
Territory (countrywise)
Therapeutic Area (e.g. infectious, oncology, gastrointestinal)
Drug Code/Name (for individual molecules)
View Full Report at http://www.marketresearchreports.biz/analysis/172485
Each project is specified for its Target, Therapeutic Area and R&D Phase. Use of the R&D database of therapeutic antibodies is intuitive. Data sets of interest can be printed and exported as reports in Excel or Word format. Projects are being updated continuously. The R&D history of each project with online references of information sources can be viewed and printed. Sales figures of major therapeutic antidoies on the market are provided. An advanced search function allows to combine search parameters. A scroll down menu for predefined targets and technologies conveniently selects projects of interest. By clicking on column heads of the project list, projects can be arranged in ascending or descending alphabetical or numerical order, e.g. for phase or company name.
Special Focus of the Database:
Antibody-Drug Conjugates
Bispecific Antibodies
Biosimilar and Biosuperior Antibodies
Download Sample Copy of this Report at http://www.marketresearchreports.biz/sample/sample/172485
See our sample screenshots of the database: Download sample screenshots
Prerequisite: Internet access
Purchase of the subscription provides a 1-year online access to the data of the Antibody Target, Technology & Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase.
Benefits from the Antibody Pipeline Database:
Intuitive use
Designed for structured searches
Focused on targets, therapeutic areas and R&D phases
Ideal for competitor analysis (companies, targets, technologies, R&D phase)
Cost-effective and rapid solution for benchmarking
Identification of licensing candidates
Project listing in a tabular format:
Drug Codes
Target
Class of Compound
Company
Territory
Therapeutic Area
Indication
R&D Phase
Therapeutic Areas:
Cardiovascular & blood
Dermatology
Gastrointestinal
Genitourinary, renal & gynecology
Infectious & toxicology
Metabolism & endocrine
Neurology & psychiatry
Oncology
Ophthalmology & otorhinolaryngology
Orthopedics, dental, anesthesia & surgery
Pulmonary & respiratory
Rheumatoid & autoimmune
Predefined Technologies of the Scroll-Down Menu - examples:
Antibody-Drug Conjugates per Payload (e.g. Auristatin, PBD)
Bispecific Antibodies
Oligo- and Polyclonal Antibodies
In vitro generated Antibodies (phage display)
Fab Antibodies
Fc-Fusion Proteins
Agonist Antibodies
Transgenic Mouse Antibodies (e.g. XenoMouse, VelocImmune Mouse, KM Mouse)
Human Cell-Derived Antibodies
Predefined Targets of the Scroll Down Menu - examples:
Alzheimer’s Disease Antibodies
Anti-Infective Antibodies
Anti-Inflammatory and –Autoimmune Antibodies
Antibody-Drug Conjugates (ADC)
Antibody Sales in 2012
Biosimilar & Biobetter/Biosuperior Antibodies
c-MET/HGF Inhibitors
CD19 Antagonists
CD20 Antibodies
EGF-R Agonists and Antagonists
GM-CSF Antibodies
Her2 Antibodies
IGF-1R Antagonists
Immunocytokines
Immunotoxins
Interleukin-1/R Antagonists
Interleukin-6/R Antagonists
Interleukin-12/23 Antagonists
Interleukin-13 Antagonists
Interleukin-17 Antagonists
Integrin Antagonists
NGF Antagonists
PCSK9 Inhibitors
PDGF-R Antagonists
TGF-R Antagonists
TNF Antagonists
TRAIL-R1/R2 (Death Receptors)
VEGF/R Antagonists
About Us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Read our latest articles at http://www.marketresearchreports.biz/articles
Contact Us
Office: State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz
Subscription to La Merie Publishing’s proprietary Antibody Database provides online access to information about more than 2,400 project entries for therapeutic antibodies on the market and in research & development. Pre-established and free search functions allow to identify antibodies according to their
Technology (e.g. antibody-drug conjugate, bispecific, isotype, phage display)
Target (e.g. Her2, CD20, TNF, PD-1/PD-L1)
Pipelines (selected by target, therapeutic area, company, technology)
Sales (for marketed antibodies)
R&D Phase (clinical phases, market, preclinical)
Territory (countrywise)
Therapeutic Area (e.g. infectious, oncology, gastrointestinal)
Drug Code/Name (for individual molecules)
View Full Report at http://www.marketresearchreports.biz/analysis/172485
Each project is specified for its Target, Therapeutic Area and R&D Phase. Use of the R&D database of therapeutic antibodies is intuitive. Data sets of interest can be printed and exported as reports in Excel or Word format. Projects are being updated continuously. The R&D history of each project with online references of information sources can be viewed and printed. Sales figures of major therapeutic antidoies on the market are provided. An advanced search function allows to combine search parameters. A scroll down menu for predefined targets and technologies conveniently selects projects of interest. By clicking on column heads of the project list, projects can be arranged in ascending or descending alphabetical or numerical order, e.g. for phase or company name.
Special Focus of the Database:
Antibody-Drug Conjugates
Bispecific Antibodies
Biosimilar and Biosuperior Antibodies
Download Sample Copy of this Report at http://www.marketresearchreports.biz/sample/sample/172485
See our sample screenshots of the database: Download sample screenshots
Prerequisite: Internet access
Purchase of the subscription provides a 1-year online access to the data of the Antibody Target, Technology & Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase.
Benefits from the Antibody Pipeline Database:
Intuitive use
Designed for structured searches
Focused on targets, therapeutic areas and R&D phases
Ideal for competitor analysis (companies, targets, technologies, R&D phase)
Cost-effective and rapid solution for benchmarking
Identification of licensing candidates
Project listing in a tabular format:
Drug Codes
Target
Class of Compound
Company
Territory
Therapeutic Area
Indication
R&D Phase
Therapeutic Areas:
Cardiovascular & blood
Dermatology
Gastrointestinal
Genitourinary, renal & gynecology
Infectious & toxicology
Metabolism & endocrine
Neurology & psychiatry
Oncology
Ophthalmology & otorhinolaryngology
Orthopedics, dental, anesthesia & surgery
Pulmonary & respiratory
Rheumatoid & autoimmune
Predefined Technologies of the Scroll-Down Menu - examples:
Antibody-Drug Conjugates per Payload (e.g. Auristatin, PBD)
Bispecific Antibodies
Oligo- and Polyclonal Antibodies
In vitro generated Antibodies (phage display)
Fab Antibodies
Fc-Fusion Proteins
Agonist Antibodies
Transgenic Mouse Antibodies (e.g. XenoMouse, VelocImmune Mouse, KM Mouse)
Human Cell-Derived Antibodies
Predefined Targets of the Scroll Down Menu - examples:
Alzheimer’s Disease Antibodies
Anti-Infective Antibodies
Anti-Inflammatory and –Autoimmune Antibodies
Antibody-Drug Conjugates (ADC)
Antibody Sales in 2012
Biosimilar & Biobetter/Biosuperior Antibodies
c-MET/HGF Inhibitors
CD19 Antagonists
CD20 Antibodies
EGF-R Agonists and Antagonists
GM-CSF Antibodies
Her2 Antibodies
IGF-1R Antagonists
Immunocytokines
Immunotoxins
Interleukin-1/R Antagonists
Interleukin-6/R Antagonists
Interleukin-12/23 Antagonists
Interleukin-13 Antagonists
Interleukin-17 Antagonists
Integrin Antagonists
NGF Antagonists
PCSK9 Inhibitors
PDGF-R Antagonists
TGF-R Antagonists
TNF Antagonists
TRAIL-R1/R2 (Death Receptors)
VEGF/R Antagonists
About Us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Read our latest articles at http://www.marketresearchreports.biz/articles
Contact Us
Office: State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz
No comments:
Post a Comment